Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03744234 · ClinicalTrials.gov registry record · NA
Platelet-rich Plasma in the Sacroiliac Joint
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03744234 is a NA study that has completed, run by Columbia University. The registered enrollment target is 40 participants.
The verdict
NCT03744234, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a double-blinded study where the injecting physicians and the patients will not know which arm they are randomized to. Each participant will be followed up for 6 months following the injection, and will have in office visits at the injection and approximately 2 weeks post injection. They will be called at month 1, 3, and 6 post injection to assess for any adverse events and number of physical therapy hours or changes in medication. At time of injection, 2 weeks post, and 1, 3 and 6 months after they will be asked to answer some questionnaires on pain and function.
Interventions
- PROCEDURE PRP
- PROCEDURE Steroid Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-12-01 |
| Est. Completion | 2019-09-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03744234
The ClinicalTrials.gov registry entry for NCT03744234 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PRP is the first listed.
NCT03744234 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03744234 about?
NCT03744234 is a clinical study titled "Platelet-rich Plasma in the Sacroiliac Joint". This is a double-blinded study where the injecting physicians and the patients will not know which arm they are randomized to. Each participant will be followed up for 6 months following the injection, and will have in office visits at the injection and approximately 2 weeks post injection. They wil...
What is the current status of trial NCT03744234?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2016-12-01. Estimated completion is 2019-09-16.
What interventions are being tested in trial NCT03744234?
The interventions under investigation include: PRP (PROCEDURE), Steroid Injection (PROCEDURE).
Who is sponsoring clinical trial NCT03744234?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.